Biotech

All Articles

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS tests

.Sanofi is still bented on taking its own numerous sclerosis (MS) med tolebrutinib to the FDA, execu...

Galapagos' stockpile as fund shows intent to form its own progression

.Galapagos is coming under additional stress from investors. Having constructed a 9.9% concern in Ga...

Cell- centered Sana scoops first CSO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of significant management hirings, shootings...

Allist settles Jacobio $21M, landing duty in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has purchased itself a starring role in China's KRAS market, paying...

ReNeuron leaving purpose swap after overlooking fundraising objective

.ReNeuron has actually signed up with the long listing of biotechs to leave behind Greater london's ...

MBX declare IPO to take opposition to Ascendis in to stage 3

.MBX Biosciences has actually included in the latest outbreak of IPO filings. The biotech, which fil...

FDA grows probing into Lykos' MDMA trials: WSJ

.For Lykos Rehabs and the firm's potential MDMA-assisted therapy for post-traumatic stress disorder ...

Gene editor Tome laying off 131 employees

.Simply days after genetics publisher Volume Biosciences declared hidden operational slices, a more ...

Repare gives up 25% of personnel as biotech halts preclinical R&ampD

.Repare Rehab is laying off an one-fourth of its workforce as the oncology biotech lessen its own pr...

J &amp J apply for FDA confirmation of $6.5 B autoimmune medicine

.Johnson &amp Johnson has actually taken another measure toward recognizing a return on its own $6.5...